How much do we really know about ageing? For decades, scientists have been trying to understand the biology of the ageing process - what happens to our bodies as we get older? And is it possible to slow that process down or even stop it all together? In this series of Tech Tonic, the FT’s Hannah Kuchler and Michael Peel look into the past, present and future of longevity - the wellness movement focused on extending and bettering your quality of life. Episode 1 follows Hannah as she speaks with UCL professor David Gems about the history of ageing research, and then with longevity researcher Matt Kaeberlein to discuss how the industry has developed - including current drugs that could have anti-ageing effects. Plus, Michael visits the Reviv clinic in London where he experiences, first hand, the growing consumer interest in the longevity craze. Read more from the FT — for free: My year-long quest to live forever The quest to make young blood into a drug Muscly people show slower brain ageing, study finds This season of Tech Tonic is presented by Hannah Kuchler and Michael Peel. It was produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Clips: @DaveAspreyBPR, @drjoshaxe, @HealthCoachKait, Hevolution, Pom, Purina, Garnier, 4G antioxidants, @ChrisWillx, @lexfridman, ABC News, C-Span, CBS, ITV This Morning, Wired UK, The Dissenter, Will Tennyson The FT does not use generative AI to voice its podcasts. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
